ArticleScientific reports2025
Novel insights into the protective role of crocetin from gardenia jasminoides against mitochondrial hypoxia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This study aimed to optimize the preparation process of crocetin from gardenia fruit via alkaline hydrolysis using Box-Behnken response surface design, and to investigate its antioxidant activity and protective effect against mitochondrial hypoxic damage. Single-factor experiments and response surface methodology were employed to optimize key parameters (reaction time, temperature, and KOH concentration) with comprehensive evaluation indicators of yield and crocetin content. The optimal conditions were determined as: reaction time 20 h, temperature 63 °C, and KOH concentration 11 mol/L. Through two-step purification (alkaline extraction and acid precipitation), crocetin with a purity of 95.28% was obtained, and its structure was confirmed by ¹H-NMR and ¹³C-NMR. In vitro antioxidant assays using three chemiluminescent systems (luminol-DMSO-NaOH, luminol-H₂O₂, and luminol-FeSO₄-H₂O₂) showed that trans-crocetin exhibited stronger scavenging activity against •O₂⁻, H₂O₂, and •OH than ascorbic acid (P < 0.05 or P < 0.001). Forced swimming experiments in rats revealed that crocetin significantly alleviated hypoxia-induced mitochondrial damage in gastrocnemius muscles, as evidenced by reduced cristae fragmentation and improved mitochondrial integrity compared to the hypoxia model group. The study demonstrates that the optimized alkaline hydrolysis process enables efficient, eco-friendly extraction of high-purity crocetin from gardenia fruit. Trans-crocetin derived from gardenia exhibits potent antioxidant properties and protective effects against mitochondrial hypoxic injury, suggesting its potential in treating hypoxia-mediated metabolic diseases and tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.